Found: 17
Select item for more details and to access through your institution.
Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 6, p. 1272, doi. 10.3390/jcm10061272
- By:
- Publication type:
- Article
Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.984132
- By:
- Publication type:
- Article
Metastatic hormone sensitive prostate cancer: local treatment strategies.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 2, p. 327, doi. 10.1007/s00345-020-03296-8
- By:
- Publication type:
- Article
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092275
- By:
- Publication type:
- Article
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1678, doi. 10.3390/cancers14071678
- By:
- Publication type:
- Article
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1573, doi. 10.3390/cancers12061573
- By:
- Publication type:
- Article
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2057, doi. 10.1002/1878-0261.13188
- By:
- Publication type:
- Article
BetaHCG secretion by a pulmonary adenocarcinoma.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Association of carcinoid tumor and low grade glioma.
- Published in:
- World Journal of Surgical Oncology, 2012, v. 10, n. 1, p. 236, doi. 10.1186/1477-7819-10-236
- By:
- Publication type:
- Article
Whole exome sequencing of rare aggressive breast cancer histologies.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 1, p. 21, doi. 10.1007/s10549-016-3718-y
- By:
- Publication type:
- Article
Corrigendum: Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.644301
- By:
- Publication type:
- Article
Clinical development of mTOR inhibitors in breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.670827
- By:
- Publication type:
- Article
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association between CD8 and PD‐L1 expression and outcomes after radical prostatectomy for localized prostate cancer.
- Published in:
- Prostate, 2021, v. 81, n. 1, p. 50, doi. 10.1002/pros.24079
- By:
- Publication type:
- Article
Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.01033
- By:
- Publication type:
- Article